Nonvalue of culturing cerebrospinal fluid for fungi

被引:18
作者
Barenfanger, J [1 ]
Lawhorn, J [1 ]
Drake, C [1 ]
机构
[1] Mem Med Ctr, Lab Med, Springfield, IL 62781 USA
关键词
D O I
10.1128/JCM.42.1.236-238.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
No studies have evaluated the efficacy of culturing cerebrospinal fluid (CSF) for fungi. Because of the facts that the most common fungi responsible for meningitis grow well in media utilized for routine bacterial cultures and that cryptococcal antigen tests are commonly ordered, the efficacy of routinely performing fungal cultures specifically to recover fungi has been questioned. We examined data from 1,225 samples of CSF which were cultured for both bacteria and fungi. Twelve specimens yielded fungi, 10 from fungal cultures and 8 from bacterial cultures. Cryptococcus neoformans was found in 10 specimens, Candida albicans was found in 1, and a Cladosporium sp. was found in 1. Eight of 12 positive specimens had concordant culture results. The discordant cases were one specimen that was bacterial culture positive but fungal culture negative and three specimens that were fungal culture positive but bacterial culture negative. Of the latter discrepant cultures, one had fungal contamination only and the other two were positive for cryptococcal antigen. Therefore, omitting the fungal cultures on these specimens would not adversely impact patients. When both cryptococcal antigen tests and bacterial cultures are ordered routinely, eliminating fungal cultures on CSF would have had no impact on the patients in this study. All the clinically significant fungi were detected by the cryptococcal antigen test and/or bacterial culture. With a few exceptions, the combined use of cryptococcal antigen test and bacterial cultures of CSF could replace routine fungal cultures of CSF. Exceptions include settings where fungal pathogens other than Cryptococcus and Candida remain important causes of meningitis.
引用
收藏
页码:236 / 238
页数:3
相关论文
共 9 条
  • [1] CEREBROSPINAL-FLUID (CSF) TRAP - A METHOD TO IMPROVE CSF LABORATORY EFFICIENCY
    ALBRIGHT, RE
    CHRISTENSON, RH
    HABIG, RL
    MEARS, TP
    SCHNEIDER, KA
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (06) : 707 - 710
  • [2] AMPEL N, 2000, FUNGAL DIS LUNG, P59
  • [3] CLINICAL-SIGNIFICANCE OF FUNGI ISOLATED FROM CEREBROSPINAL-FLUID IN CHILDREN
    ARISOY, ES
    ARISOY, AE
    DUNNE, WM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (02) : 128 - 133
  • [4] Gripshover BM, 2000, PRINCIPLES PRACTICE, P997
  • [5] Cost and time savings following introduction of rejection criteria for clinical specimens
    Morris, AJ
    Smith, LK
    Mirrett, S
    Reller, LB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) : 355 - 357
  • [6] Practice guidelines for the management of cryptococcal disease
    Saag, MS
    Graybill, RJ
    Larsen, RA
    Pappas, PG
    Perfect, JR
    Powderly, WG
    Sobel, JD
    Dismukes, WE
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) : 710 - 718
  • [7] Sturgis CD, 1997, AM J CLIN PATHOL, V108, P217
  • [8] Laboratory diagnosis of central nervous system infections
    Thomson, RB
    Bertram, H
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2001, 15 (04) : 1047 - +
  • [9] TUNKEL AR, 2000, PRINCIPLES PRACTICE, P959